Target type: biologicalprocess
The alteration of the N-terminal amino acid residue in a protein. [GOC:mah]
N-terminal protein amino acid modification is a fundamental process in cellular biology that plays a crucial role in regulating protein function, stability, and localization. It involves the enzymatic modification of the N-terminal amino acid residue of a newly synthesized protein, often occurring co-translationally. This modification can dramatically alter the protein's properties and determine its fate within the cell.
The N-terminus of a protein is typically characterized by a methionine residue, encoded by the start codon AUG. However, this methionine is often removed or modified through a series of enzymatic steps. These modifications can involve:
1. **Methionine Removal:** The N-terminal methionine can be cleaved by methionine aminopeptidase (MetAP), a ubiquitous enzyme present in all organisms. MetAP recognizes the N-terminal methionine and its adjacent residue. The presence of bulky or negatively charged residues at the second position (P2) generally favors cleavage. This removal is critical for the proper folding, stability, and activity of many proteins.
2. **Acetylation:** N-terminal acetylation is a widespread modification where an acetyl group (CH3CO) is added to the α-amino group of the N-terminal residue. This modification is catalyzed by N-terminal acetyltransferases (NATs), which are diverse and can exhibit substrate specificity. Acetylation can enhance protein stability by protecting the N-terminus from proteolytic degradation, promote proper folding, and facilitate protein-protein interactions.
3. **Myristoylation:** This modification involves the attachment of myristate, a 14-carbon saturated fatty acid, to the N-terminal glycine residue. This modification is catalyzed by N-myristoyltransferases (NMTs) and is often found in proteins involved in membrane association, signal transduction, and protein-protein interactions.
4. **Other Modifications:** Additional modifications at the N-terminus include:
* **Glycosylation:** The addition of sugar moieties to the N-terminus, often found in secreted proteins.
* **Phosphorylation:** The addition of a phosphate group, which can regulate protein activity and localization.
* **Ubiquitylation:** The attachment of ubiquitin, a small protein that can target proteins for degradation.
The specific N-terminal modifications that occur on a given protein are determined by its amino acid sequence, cellular localization, and function. These modifications are crucial for proper protein function and play significant roles in various cellular processes, including:
* **Protein folding and stability:** N-terminal modifications can influence protein folding and stability by affecting interactions with chaperones and other proteins.
* **Protein trafficking and localization:** Modifications can direct proteins to specific cellular compartments or membranes.
* **Protein-protein interactions:** N-terminal modifications can create or alter binding sites for other proteins.
* **Protein activity:** N-terminal modifications can activate or inhibit protein function.
In summary, N-terminal protein amino acid modification is a complex and diverse process that plays a vital role in regulating protein function and fate within the cell. Understanding these modifications is critical for comprehending the intricate mechanisms of cellular processes and for developing therapeutic strategies targeting protein function.'
"
Protein | Definition | Taxonomy |
---|---|---|
Peptide deformylase, mitochondrial | A peptide deformylase, mitochondrial that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9HBH1] | Homo sapiens (human) |
Methionine aminopeptidase 1 | A methionine aminopeptidase 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P53582] | Homo sapiens (human) |
Methionine aminopeptidase 2 | A methionine aminopeptidase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P50579] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
2,2'-dipyridyl | 2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'. 2,2'-Dipyridyl: A reagent used for the determination of iron. | bipyridine | chelator; ferroptosis inhibitor |
oxyquinoline | Oxyquinoline: An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics. quinolin-8-ol : A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes. | monohydroxyquinoline | antibacterial agent; antifungal agrochemical; antiseptic drug; iron chelator |
cloxyquin | cloxyquin: has antitubercular activity; structure in first source | organochlorine compound; quinolines | |
ebselen | ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase. | benzoselenazole | anti-inflammatory drug; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 3.5.4.1 (cytosine deaminase) inhibitor; EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor; enzyme mimic; ferroptosis inhibitor; genotoxin; hepatoprotective agent; neuroprotective agent; radical scavenger |
thiabendazole | Tresaderm: dermatologic soln containing dexamethasone, thiabendazole & neomycin sulfate | 1,3-thiazoles; benzimidazole fungicide; benzimidazoles | antifungal agrochemical; antinematodal drug |
8-hydroxyquinoline-5-sulfonic acid | 8-hydroxyquinoline-5-sulfonic acid: RN given refers to parent cpd | ||
dimoxyline | quinolines | ||
8-hydroxy-2-methylquinoline | 8-hydroxy-2-methylquinoline: structure in first source | hydroxyquinoline | |
nitroxoline | nitroxoline : A monohydroxyquinoline in which the hydroxy group is positioned at C-8 with a nitro group trans to it at C-5. nitroxoline: structure in Merck Index, 9th ed, #6475; RN given refers to parent cpd | C-nitro compound; monohydroxyquinoline | antifungal agent; antiinfective agent; antimicrobial agent; renal agent |
2-(2'-pyridyl)benzimidazole | 2-(2'-pyridyl)benzimidazole: structure in first source | ||
1-amino-1-phenylmethyl phosphonic acid | 1-amino-1-phenylmethyl phosphonic acid : A member of the class of phosphonic acids that is phosphonic acid having a amino(phenyl)methyl group attached to the phosphorus. | benzenes; phosphonic acids; primary amino compound | |
bis(2-(n-phenylcarboxamido)phenyl)diselenide | bis(2-(N-phenylcarboxamido)phenyl)diselenide: selenoorganic cpd which has mitogenic activity in human peripheral leukocytes | ||
bb3497 | BB3497: peptide deformylase inhibitor; structure in first source | ||
8-(4-benzenesulfonylamino)quinoline | 8-(4-benzenesulfonylamino)quinoline: has diabetogenic properties; structure given in first source | ||
o-(chloroacetylcarbamoyl)fumagillol | O-(chloroacetylcarbamoyl)fumagillol : A carbamate ester that is fumagillol in which the hydroxy group has been converted to the corresponding N-(chloroacetyl)carbamate derivative. O-(Chloroacetylcarbamoyl)fumagillol: Semisynthetic analog of fumagillin (a cyclohexane-sesquiterpene antibiotic isolated from ASPERGILLUS FUMIGATUS) that inhibits angiogenesis. | carbamate ester; organochlorine compound; semisynthetic derivative; sesquiterpenoid; spiro-epoxide | angiogenesis inhibitor; antineoplastic agent; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; methionine aminopeptidase 2 inhibitor; retinoic acid receptor alpha antagonist |
actinonin | actinonin: natural hydroxamic acid, pseudopeptide antibiotic isolated from Streptomyces species; structure | ||
4,5-dimethylaminobenzylidene-2-thiobarbituric acid | |||
pyridine-2-carboxylic acid thiazol-2-ylamide | pyridine-2-carboxylic acid thiazol-2-ylamide: structure in first source | ||
fumagillin | antibiotic antifungal drug; carboxylic ester; dicarboxylic acid monoester; meroterpenoid; organooxygen heterocyclic antibiotic; spiro-epoxide | angiogenesis inhibitor; antibacterial drug; antimicrobial agent; antiprotozoal drug; fungal metabolite; methionine aminopeptidase 2 inhibitor | |
ppi 2458 | PPI 2458: a methionine aminopeptidase-2 inhibitor with antirheumatic activity; structure in first source |